Intelligent Bio-Systems exclusively licensed DNA sequencing technology from Columbia University.
Beckman Coulter appointed James V. Mazzo, president and CEO of Advanced Medical Optics, to its board.
Under a collaboration agreement, BG Medicine will integrate Applied Biosystems technology into its proteomic and metabolomic systems pharmacology workflows.
Kyodo International will represent lab-on-a-chip company Micronit Microfluidics BV in Japan.
Quest Diagnostics signed a worldwide licensing agreement with US Genomics, granting it the right to develop an advanced screening method for Fragile X Syndrome.
Fluidigm appointed Dominique Remy-Renou vice president of European Sales and Support, and General Manager of Fluidigm Europe BV. She was country manager for Applied Biosystems France from 1997 to 2005.
Agilent and Lipomics Technologies are collaborating to develop research and diagnostic assays focused on metabolic diseases.
Bio-Rad Laboratories appointed Louis Drapeau to its board in February. He is CFO and senior vice president of Finance at Nektar Therapeutics.
Digital microfluidics firm Advanced Liquid Logic acquired Nanolytics in February. Advanced Liquid Logic will launch its first product this year.
In March, Applied Biosystems officially opened its 5,400 square feet Asia Pacific Application Support Center in Shanghai, China, housing five demonstration labs.
Applied Precision will manufacture a fully automated, high-speed fluorescence imager to be distributed by NanoStrong Technologies as a component of its nCounter System for gene expression.
Leica Microsystems will exclusively distribute Mauna Kea Technologies’ Cellvizio endoscopic confocal microscope system for in vivo research in Europe, North America and Japan. It will be marketed as the Leica FCM1000.